Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo

BackgroundCalorie restriction (CR) produces a number of health benefits and ameliorates diseases of aging such as type 2 diabetes. The components of the pathways downstream of CR may provide intervention points for developing therapeutics for treating diseases of aging. The NAD+-dependent protein deacetylase SIRT1 has been implicated as one of the key downstream regulators of CR in yeast, rodents, and humans. Small molecule activators of SIRT1 have been identified that exhibit efficacy in animal models of diseases typically associated with aging including type 2 diabetes. To identify molecular processes induced in the liver of mice treated with two structurally distinct SIRT1 activators, SIRT501 (formulated resveratrol) and SRT1720, for three days, we utilized a systems biology approach and applied Causal Network Modeling (CNM) on gene expression data to elucidate downstream effects of SIRT1 activation.ResultsHere we demonstrate that SIRT1 activators recapitulate many of the molecular events downstream of CR in vivo, such as enhancing mitochondrial biogenesis, improving metabolic signaling pathways, and blunting pro-inflammatory pathways in mice fed a high fat, high calorie diet.ConclusionCNM of gene expression data from mice treated with SRT501 or SRT1720 in combination with supporting in vitro and in vivo data demonstrates that SRT501 and SRT1720 produce a signaling profile that mirrors CR, improves glucose and insulin homeostasis, and acts via SIRT1 activation in vivo. Taken together these results are encouraging regarding the use of small molecule activators of SIRT1 for therapeutic intervention into type 2 diabetes, a strategy which is currently being investigated in multiple clinical trials.

[1]  Namjin Chung,et al.  Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ , 2004, Nature.

[2]  L. Partridge,et al.  Dietary restriction in Drosophila , 2005, Mechanisms of Ageing and Development.

[3]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[4]  H. Chung,et al.  The Inflammation Hypothesis of Aging , 2001 .

[5]  J. Halter,et al.  Caloric restriction mimetics: metabolic interventions. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[6]  V. Giguère,et al.  Estrogen-Related Receptor α Directs Peroxisome Proliferator-Activated Receptor α Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle , 2004, Molecular and Cellular Biology.

[7]  G. Bray,et al.  Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. , 2005, The Journal of clinical investigation.

[8]  D. L. Le Couteur,et al.  Life Extension by Calorie Restriction in Humans , 2007, Annals of the New York Academy of Sciences.

[9]  J. Plutzky,et al.  Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. , 2007, Circulation.

[10]  Jack Coulehan,et al.  Family History , 2014, Annals of Internal Medicine.

[11]  G. Ferns,et al.  The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. , 2006, Atherosclerosis.

[12]  J. Cidlowski,et al.  Mechanisms of glucocorticoid receptor signaling during inflammation , 2004, Mechanisms of Ageing and Development.

[13]  J. Auwerx,et al.  Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. , 2008, Cell metabolism.

[14]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[15]  J. Davis.  Bioinformatics and Computational Biology Solutions Using R and Bioconductor , 2007 .

[16]  M. Christian,et al.  Metabolic regulation by the nuclear receptor corepressor RIP140 , 2006, Trends in Endocrinology & Metabolism.

[17]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[18]  G. Bray,et al.  Family History of Diabetes Links Impaired Substrate Switching and Reduced Mitochondrial Content in Skeletal Muscle , 2007, Diabetes.

[19]  A. Bartke,et al.  PPARs in Calorie Restricted and Genetically Long-Lived Mice , 2006, PPAR research.

[20]  P. Robbins,et al.  Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription. , 2007, The Biochemical journal.

[21]  Steven P Gygi,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.

[22]  Emilio Clementi,et al.  Calorie Restriction Promotes Mitochondrial Biogenesis by Inducing the Expression of eNOS , 2005, Science.

[23]  S. Kersten,et al.  PPARs, Obesity, and Inflammation , 2006, PPAR research.

[24]  E. Ravussin,et al.  Calorie restriction and aging: review of the literature and implications for studies in humans. , 2003, The American journal of clinical nutrition.

[25]  S. Nemoto,et al.  SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1α* , 2005, Journal of Biological Chemistry.

[26]  N. Elmalı,et al.  Effects of Resveratrol in Inflammatory Arthritis , 2007, Inflammation.

[27]  David Sinclair,et al.  Sirtuins in mammals: insights into their biological function. , 2007, The Biochemical journal.

[28]  P. Barnes,et al.  Treatment of airway mucus hypersecretion , 2006, Annals of medicine.

[29]  L. N. Valenti,et al.  Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes* , 2005, Journal of Biological Chemistry.

[30]  L. Guarente,et al.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR. , 2007, Molecular cell.

[31]  Eric Verdin,et al.  Conserved metabolic regulatory functions of sirtuins. , 2008, Cell metabolism.

[32]  Amy V. Lynch,et al.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.

[33]  M. McVey,et al.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. , 1999, Genes & development.

[34]  B. Chandrasekar,et al.  Inhibition of inflammatory response in transgenic fat-1 mice on a calorie-restricted diet. , 2006, Biochemical and biophysical research communications.

[35]  J. Auwerx,et al.  Sirtuins: The ‘magnificent seven’, function, metabolism and longevity , 2007, Annals of medicine.

[36]  N. Holden,et al.  Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor? , 2007, Molecular Pharmacology.

[37]  S. Minucci,et al.  Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence , 2002, The EMBO journal.

[38]  Thomas Mammone,et al.  SIRT1 promotes differentiation of normal human keratinocytes. , 2009, The Journal of investigative dermatology.

[39]  N. Hacohen,et al.  Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-κB activation by TNF-α is obligatory , 2002 .

[40]  U. Jeschke,et al.  Peroxisome Proliferator‐Activated Receptors: New Players in the Field of Reproduction , 2007, American journal of reproductive immunology.

[41]  Cuk-Seong Kim,et al.  SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase , 2007, Proceedings of the National Academy of Sciences.

[42]  G. Williams.  Antitumor necrosis factor-alpha therapy and potential cancer inhibition. , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[43]  S. Nicosia,et al.  Suppression of FOXO1 activity by FHL2 through SIRT1‐mediated deacetylation , 2005, The EMBO journal.

[44]  P. Puigserver,et al.  Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-α , 2005, International Journal of Obesity.

[45]  E. Ravussin,et al.  Energy restriction and aging , 2004, Current opinion in clinical nutrition and metabolic care.

[46]  P. Elliott,et al.  SIRT1 activation confers neuroprotection in experimental optic neuritis. , 2007, Investigative ophthalmology & visual science.

[47]  E. Oakeley,et al.  The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Poulsen,et al.  SIRT1 Modulating Compounds from High-Throughput Screening as Anti-Inflammatory and Insulin-Sensitizing Agents , 2006, Journal of biomolecular screening.

[49]  L. Guarente,et al.  Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans , 2001, Nature.

[50]  K. Tronstad,et al.  The metabolic syndrome and the hepatic fatty acid drainage hypothesis. , 2005, Biochimie.

[51]  M. Mattson,et al.  Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. , 2007, Free radical biology & medicine.

[52]  J. Auwerx,et al.  Transcriptional coregulators in the control of energy homeostasis. , 2007, Trends in cell biology.

[53]  Steven P. Gygi,et al.  Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.

[54]  B. Spiegelman,et al.  Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. , 2006, Endocrine reviews.

[55]  N. Hacohen,et al.  Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. , 2002, Diabetes.

[56]  T. Shioi,et al.  Resveratrol ameliorates experimental autoimmune myocarditis. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[57]  B. Rogina,et al.  Sir2 mediates longevity in the fly through a pathway related to calorie restriction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Min Zhu,et al.  Calorie restriction mimetics: an emerging research field , 2006, Aging cell.

[59]  J. Wood,et al.  Sirtuin activators mimic caloric restriction and delay ageing in metazoans , 2004, Nature.

[60]  R. Medema,et al.  FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2SIRT1* , 2004, Journal of Biological Chemistry.

[61]  O. Boss,et al.  Targeting PGC-1α to control energy homeostasis , 2007, Expert opinion on therapeutic targets.

[62]  D. G. Newman,et al.  Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. , 2003, The Journal of clinical endocrinology and metabolism.

[63]  R. Weinberg,et al.  hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.

[64]  D. Ingram,et al.  Calorie restriction in nonhuman primates: assessing effects on brain and behavioral aging , 2007, Neuroscience.

[65]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[66]  W. Yong,et al.  Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. , 2008, Biochemical and biophysical research communications.

[67]  A. Elsharkawy,et al.  Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis , 2007 .

[68]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[69]  I. Rahman,et al.  Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[70]  C. Ballantyne,et al.  Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. , 2004, The Journal of clinical endocrinology and metabolism.

[71]  Eric Ravussin,et al.  Calorie Restriction Increases Muscle Mitochondrial Biogenesis in Healthy Humans , 2007, PLoS medicine.

[72]  C. Burant,et al.  Role of FoxO1 in FFA-induced oxidative stress in adipocytes. , 2007, American journal of physiology. Endocrinology and metabolism.

[73]  J. Holloszy,et al.  Caloric restriction in humans , 2007, Experimental Gerontology.

[74]  L. Guarente,et al.  Genetic links between diet and lifespan: shared mechanisms from yeast to humans , 2007, Nature Reviews Genetics.

[75]  V. Giguère,et al.  Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. , 2004, Molecular and cellular biology.

[76]  H. Berlie,et al.  Evolution of Peroxisome Proliferator-Activated Receptor Agonists , 2007, The Annals of pharmacotherapy.

[77]  A. Elsharkawy,et al.  Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. , 2007, Hepatology.

[78]  P. Tak,et al.  Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. , 2008, Pharmacology & therapeutics.

[79]  D. Ingram,et al.  Caloric Restriction in Primates and Relevance to Humans , 2001, Annals of the New York Academy of Sciences.

[80]  Myriam Gorospe,et al.  Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase , 2004, Science.

[81]  H. Chung,et al.  The inflammation hypothesis of aging: molecular modulation by calorie restriction. , 2001, Annals of the New York Academy of Sciences.

[82]  J. Auwerx,et al.  PGC-1α Turbocharging mitochondria , 2004, Cell.

[83]  D. Sinclair.  Toward a unified theory of caloric restriction and longevity regulation , 2005, Mechanisms of Ageing and Development.

[84]  Jimmy D Bell,et al.  The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance , 2007, Nuclear receptor.

[85]  Rafael A. Irizarry,et al.  Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .

[86]  I. Rahman,et al.  SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[87]  L. Guarente.  Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins? , 2008, Cell.

[88]  H. Chung,et al.  Modulation of PPAR in aging, inflammation, and calorie restriction. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[89]  P. Arner,et al.  Tumour necrosis factor‐α in human adipose tissue – from signalling mechanisms to clinical implications , 2007, Journal of internal medicine.

[90]  P. Puigserver.  Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. , 2005, International journal of obesity.

[91]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[92]  Steve Hoberman,et al.  A computational model to define the molecular causes of type 2 diabetes mellitus. , 2005, Diabetes technology & therapeutics.

[93]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[94]  O. Mathieu-Costello,et al.  Mitochondrial biogenesis during cellular differentiation. , 1997, The American journal of physiology.

[95]  J. Auwerx,et al.  PGC-1alpha: turbocharging mitochondria. , 2004, Cell.